Sost Deficiency does not Alter Bone’s Lacunar or Vascular Porosity in Mice

SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone formation. In humans, mutations in the SOST gene lead to skeletal overgrowth and increased bone mineral density, suggesting that SCLEROSTIN is a key regulator of bone mass. The function of SCLEROSTIN as...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Mater
Autors principals: Mosey, Henry, Núñez, Juan A., Goring, Alice, Clarkin, Claire E., Staines, Katherine A., Lee, Peter D., Pitsillides, Andrew A., Javaheri, Behzad
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5769812/
https://ncbi.nlm.nih.gov/pubmed/29349060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmats.2017.00027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars